| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.3 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.059 | 0.3 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |